Sandra Milligan's Net Worth
$970 Thousand
Who is Sandra Milligan?
Sandra Milligan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Organon & Co., Gossamer Bio, Inc., Aspira Women's Health Inc., and Spyre Therapeutics, Inc..
SEC CIK
Sandra Milligan's CIK is 0001859810
Past Insider Trading and Trends
2021 was Sandra Milligan's most active year for acquiring shares with 14 total transactions. Sandra Milligan's most active month to acquire stocks was the month of May. 2022 was Sandra Milligan's most active year for disposing of shares, totalling 8 transactions. Sandra Milligan's most active month to dispose stocks was the month of April. 2021 saw Sandra Milligan paying a total of $0.00 for 495,863 shares, this is the most they've acquired in one year. In 2022 Sandra Milligan cashed out on 24,705 shares for a total of $203,380.21, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Organon & Co. (OGN) Snapshot price: $20.49
Head Research & Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.92% | 2.82K |
$24.24 | -$52,552.32 | 28.6K |
May 4
| |||
Form 4
| +4.34% | 1.07K |
$24.63 | -$20,344.38 | 25.78K |
May 1
| |||
Form 4
| +18.45% | 3.85K |
$23.09 | -$48,835.35 | 24.71K |
Mar 31
| |||
Form 4
| +36.96% | 5.63K |
$25.09 | -$58,861.14 | 20.86K |
Feb 28
| |||
Form 4
| +41.87% | 4.5K |
$32.36 | -$75,428.64 | 15.23K |
May 3 - May 4
| |||
Form 4
| +14.46% | 1.36K |
$32.33 | -$17,458.20 | 10.74K |
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
| +336.28% | 7.23K |
$37.57 | -$110,493.37 | 9.38K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gossamer Bio, Inc. (GOSS) Snapshot price: $0.9657
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
∞
| 32K |
$0.79 | $25,212.80 | 32K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aspira Women's Health Inc. (AWH) Snapshot price: $1
President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spyre Therapeutics, Inc. (AGLE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||